These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 9134172
1. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Jantunen E, Ruutu P, Niskanen L, Volin L, Parkkali T, Koukila-Kähkölä P, Ruutu T. Bone Marrow Transplant; 1997 Apr; 19(8):801-8. PubMed ID: 9134172 [Abstract] [Full Text] [Related]
2. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Hovi L, Saarinen-Pihkala UM, Vettenranta K, Saxen H. Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280 [Abstract] [Full Text] [Related]
3. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases. Martino R, Nomdedéu J, Altés A, Sureda A, Brunet S, Martínez C, Domingo-Albós A. Bone Marrow Transplant; 1994 Mar; 13(3):265-9. PubMed ID: 8199569 [Abstract] [Full Text] [Related]
7. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT. Solano C, Martinez C, Brunet S, Tomás JF, Urbano-Ispizua A, Zuazu J, Ojeda E, Bargay J, Moraleda JM, Bailen A, Sierra J, García-Conde J, Rozman C. Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714 [Abstract] [Full Text] [Related]
8. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. Lamparelli T, Van Lint MT, Gualandi F, Occhini D, Barbanti M, Sacchi N, Ficai G, Ghinatti C, Ferrara GB, Delfino L, Pozzi S, Morabito A, Zikos P, Vitale V, Corvo R, Frassoni F, Bacigalupo A. Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278 [Abstract] [Full Text] [Related]
9. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation. Michallet M, Perrin MC, Belhabri A, Molina L, Nicolini F, Tigaud JD, Sotto JJ, Guyotat D, Fière D, Archimbaud E. Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799 [Abstract] [Full Text] [Related]
10. Graft-versus-host disease in children: the AIEOP-BMT Group experience with cyclosporin A. Locatelli F, Uderzo C, Dini G, Zecca M, Arcese W, Messina C, Andolina M, Miniero R, Porta F, Rovelli A. Bone Marrow Transplant; 1993 Dec; 12(6):627-33. PubMed ID: 8136746 [Abstract] [Full Text] [Related]
14. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination. Trenschel R, Peceny R, Runde V, Elmaagacli A, Dermoumi H, Heintschel von Heinegg E, Müller KD, Schaefer UW, Beelen DW. Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279 [Abstract] [Full Text] [Related]